Prospective Double Blind Randomized Trial of Intramuscular Ziprasidone Compared With Standard Antipsychotic Therapy For The Treatment Of The Acutely Agitated Patient In The Emergency Department.
Withdrawn prior to enrolment
Phase of Trial: Phase IV
Latest Information Update: 15 Sep 2017
At a glance
- Drugs Ziprasidone (Primary) ; Haloperidol; Lorazepam
- Indications Agitation
- Focus Therapeutic Use
- 12 Sep 2017 Planned End Date changed from 1 Jan 2010 to 1 July 2011.
- 12 Sep 2017 Planned primary completion date changed from 1 Jan 2010 to 1 July 2011.
- 12 Sep 2017 Status changed from active, no longer recruiting to withdrawn prior to enrolment.